The green tea component EGCG inhibits RNA polymerase III transcription

Biochemical and Biophysical Research Communications

Volumn 360, Issue 4, 2007, Pages 778-783

  Jacob, Joby ^a   Cabarcas, Stephanie ^a   Veras, Ingrid ^a   Zaveri, Nurulain ^b   Schramm, Laura ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

Brf1; Brf2; EGCG; RNA polymerase III; TFIIIB

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; EPIGALLOCATECHIN GALLATE; MITOGEN ACTIVATED PROTEIN KINASE 1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA; UTERINE CERVIX CARCINOMA;

BASE SEQUENCE; CATECHIN; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RNA POLYMERASE III; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TEA; TRANSCRIPTION FACTOR TFIIIB; TRANSCRIPTION, GENETIC;

EID: 34447547506     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.114     Document Type: Article

References (53)

1. Zaveri N.T. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci. 78 18 (2006) 2073-2080
2. Horie N., Hirabayashi N., Takahashi Y., Miyauchi Y., Taguchi H., and Takeishi K. Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells. Biol. Pharm. Bull. 28 4 (2005) 574-579
3. Mukhtar H., and Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr. 71 6 Suppl. (2000) 1698S-1702S discussion 1703S-1704S
4. Yang C.S., Lambert J.D., Hou Z., Ju J., Lu G., and Hao X. Molecular targets for the cancer preventive activity of tea polyphenols. Mol. Carcinog. 45 6 (2006) 431-435
5. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 25-54
6. Yang C.S., Sang S., Lambert J.D., Hou Z., Ju J., and Lu G. Possible mechanisms of the cancer-preventive activities of green tea. Mol. Nutr. Food Res. 50 2 (2006) 170-175
7. Annabi B., Lachambre M.P., Bousquet-Gagnon N., Page M., Gingras D., and Beliveau R. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta 1542 1-3 (2002) 209-220
8. Nam S., Smith D.M., and Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276 16 (2001) 13322-13330
9. Hernaez J.F., Xu M., and Dashwood R.H. Antimutagenic activity of tea towards 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline: effect of tea concentration and brew time on electrophile scavenging. Mutat. Res. 402 1-2 (1998) 299-306
10. Kuroda Y., and Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. 436 1 (1999) 69-97
11. Lambert J.D., and Yang C.S. Mechanisms of cancer prevention by tea constituents. J. Nutr. 133 10 (2003) 3262S-3267S
12. Kim J., Zhang X., Rieger-Christ K.M., Summerhayes I.C., Wazer D.E., Paulson K.E., and Yee A.S. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J. Biol. Chem. 281 16 (2006) 10865-10875
13. Kumar N., Shibata D., Helm J., Coppola D., and Malafa M. Green tea polyphenols in the prevention of colon cancer. Front. Biosci. 12 (2007) 2309-2315
14. Schramm L., and Hernandez N. Recruitment of RNA polymerase III to its target promoters. Genes Dev. 16 20 (2002) 2593-2620
15. White R.J. RNA polymerase III transcription and cancer. Oncogene 23 18 (2004) 3208-3216
16. White R.J. RNA polymerase III transcription-a battleground for tumour suppressors and oncogenes. Eur. J. Cancer 40 1 (2004) 21-27
17. White R.J. RNA polymerases I and III, growth control and cancer. Nat. Rev. Mol. Cell. Biol. 6 1 (2005) 69-78
18. Kassavetis G.A., and Geiduschek E.P. Transcription factor TFIIIB and transcription by RNA polymerase III. Biochem. Soc. Trans. 34 Pt 6 (2006) 1082-1087
19. McCulloch V., Hardin P., Peng W., Ruppert J.M., and Lobo-Ruppert S.M. Alternatively spliced hBRF variants function at different RNA polymerase III promoters. EMBO J. 19 15 (2000) 4134-4143
20. Schramm L., Pendergrast P.S., Sun Y., and Hernandez N. Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters. Genes Dev. 14 20 (2000) 2650-2663
21. Teichmann M., Wang Z., and Roeder R.G. A stable complex of a novel transcription factor IIB-related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements. Proc. Natl. Acad. Sci. USA 97 26 (2000) 14200-14205
22. Mital R., Kobayashi R., and Hernandez N. RNA polymerase III transcription from the human U6 and adenovirus type 2 VAI promoters has different requirements for human BRF, a subunit of human TFIIIB. Mol. Cell. Biol. 16 12 (1996) 7031-7042
23. Wang Z., and Roeder R.G. Structure and function of a human transcription factor TFIIIB subunit that is evolutionarily conserved and contains both TFIIB-and high-mobility-group protein 2-related domains. Proc. Natl. Acad. Sci. USA 92 15 (1995) 7026-7030
24. Morton J.P., Kantidakis T., and White R.J. RNA polymerase III transcription is repressed in response to the tumour suppressor ARF. Nucleic Acids Res. 35 9 (2007) 3046-3052
25. Stein T., Crighton D., Warnock L.J., Milner J., and White R.J. Several regions of p53 are involved in repression of RNA polymerase III transcription. Oncogene 21 36 (2002) 5540-5547
26. Stein T., Crighton D., Boyle J.M., Varley J.M., and White R.J. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome. Oncogene 21 19 (2002) 2961-2970
27. Crighton D., Woiwode A., Zhang C., Mandavia N., Morton J.P., Warnock L.J., Milner J., White R.J., and Johnson D.L. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J. 22 11 (2003) 2810-2820
28. Cairns C.A., and White R.J. p53 is a general repressor of RNA polymerase III transcription. EMBO J. 17 11 (1998) 3112-3123
29. Chesnokov I., Chu W.M., Botchan M.R., and Schmid C.W. p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner. Mol. Cell. Biol. 16 12 (1996) 7084-7088
30. Felton-Edkins Z.A., Kenneth N.S., Brown T.R., Daly N.L., Gomez-Roman N., Grandori C., Eisenman R.N., and White R.J. Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 2 3 (2003) 181-184
31. Chu W.M., Wang Z., Roeder R.G., and Schmid C.W. RNA polymerase III transcription repressed by Rb through its interactions with TFIIIB and TFIIIC2. J. Biol. Chem. 272 23 (1997) 14755-14761
32. Sutcliffe J.E., Cairns C.A., McLees A., Allison S.J., Tosh K., and White R.J. RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130. Mol. Cell. Biol. 19 6 (1999) 4255-4261
33. Gomez-Roman N., Grandori C., Eisenman R.N., and White R.J. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421 6920 (2003) 290-294
34. Felton-Edkins Z.A., Fairley J.A., Graham E.L., Johnston I.M., White R.J., and Scott P.H. The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB. EMBO J. 22 10 (2003) 2422-2432
35. Reina J.H., Azzouz T.N., and Hernandez N. Maf1, a New Player in the Regulation of Human RNA Polymerase III Transcription. PLoS ONE 1 (2006) e134
36. Johnson S.S., Zhang C., Fromm J., Willis I.M., and Johnson D.L. Mammalian maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol. Cell 26 3 (2007) 367-379
37. Rollins J., Veras I., Cabarcas S., Willis I., and Schramm L. Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2. Int. J. Biol. Sci. 3 5 (2007) 292-302
38. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., and Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21 13 (2005) 2933-2942
39. Sartippour M.R., Pietras R., Marquez-Garban D.C., Chen H.W., Heber D., Henning S.M., Sartippour G., Zhang L., Lu M., Weinberg O., Rao J.Y., and Brooks M.N. The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27 12 (2006) 2424-2433
40. Upadhya R., Lee J., and Willis I.M. Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription. Mol. Cell 10 6 (2002) 1489-1494
41. Geiduschek E.P., and Kassavetis G.A. Transcription: adjusting to adversity by regulating RNA polymerase. Curr. Biol. 16 19 (2006) R849-R851
42. Willis I.M., and Moir R.D. Integration of nutritional and stress signaling pathways by Maf1. Trends Biochem. Sci. 32 2 (2007) 51-53
43. Khan N., Afaq F., Saleem M., Ahmad N., and Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66 5 (2006) 2500-2505
44. Lin J.K. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch. Pharm. Res. 25 5 (2002) 561-571
45. Ahmad N., Gupta S., and Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch. Biochem. Biophys. 376 2 (2000) 338-346
46. Levites Y., Youdim M.B., Maor G., and Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem. Pharmacol. 63 1 (2002) 21-29
47. Fang M., Chen D., and Yang C.S. Dietary polyphenols may affect DNA methylation. J. Nutr. 137 1 Suppl (2007) 223S-228S
48. Fujimura Y., Umeda D., Kiyohara Y., Sunada Y., Yamada K., and Tachibana H. The involvement of the 67 kDa laminin receptor-mediated modulation of cytoskeleton in the degranulation inhibition induced by epigallocatechin-3-O-gallate. Biochem. Biophys. Res. Commun. 348 2 (2006) 524-531
49. Smith D.M., Daniel K.G., Wang Z., Guida W.C., Chan T.H., and Dou Q.P. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design. Proteins 54 1 (2004) 58-70
50. Na H.K., and Surh Y.J. Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate. Mol. Nutr. Food Res. 50 2 (2006) 152-159
51. Yamamoto T., Hsu S., Lewis J., Wataha J., Dickinson D., Singh B., Bollag W.B., Lockwood P., Ueta E., Osaki T., and Schuster G. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J. Pharmacol. Exp. Ther. 307 1 (2003) 230-236
52. Yamamoto T., Lewis J., Wataha J., Dickinson D., Singh B., Bollag W.B., Ueta E., Osaki T., Athar M., Schuster G., and Hsu S. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects. J. Pharmacol. Exp. Ther. 308 1 (2004) 317-323
53. Shimizu M., Deguchi A., Joe A.K., McKoy J.F., Moriwaki H., and Weinstein I.B. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J. Exp. Ther. Oncol. 5 1 (2005) 69-78